As a purchasing manager in oncology research, you face skyrocketing API costs, inconsistent quality, and delays from unreliable suppliers. Our onartuzumab delivers c-Met inhibition precision with 35% lower prices, full DMF/FDA compliance, and door-to-door shipping to USA labs in under 7 days.
In the fast-evolving landscape of oncology research and pharmaceutical development, onartuzumab stands out as a pivotal monoclonal antibody targeting the c-Met receptor tyrosine kinase. Known also as MetMAb, onartuzumab inhibits the HGF/c-Met signaling pathway, which is hyperactive in various cancers including non-small cell lung cancer (NSCLC), glioblastoma, and gastric cancer. For corporate purchasing managers and technical directors in USA-based labs, securing high-purity onartuzumab API is not just about procurement—it's about accelerating your R&D pipeline while minimizing risks.
At Global Technology Co., Ltd, we specialize in the production and export of premium APIs like onartuzumab, backed by investments in GMP-certified manufacturers and collaborations with top university laboratories. Our onartuzumab is synthesized to exceed 99.9% purity, meeting stringent DMF and FDA standards for research and clinical applications. Why does this matter in 2026? With global supply chains strained by regulatory shifts and rising demand for targeted therapies, reliable suppliers are scarce. We've optimized our China-based operations for seamless export to English-speaking regions, particularly the USA, ensuring compliance with import regulations like FDA 21 CFR Part 11.
Imagine streamlining your procurement: no more sifting through low-quality alternatives from unverified sources. Our buy onartuzumab process offers gram-to-tonnage quantities, OEM/ODM customization, and high-speed delivery that cuts lead times by 50%. Drawing from industry data from IQVIA reports, over 60% of pharma buyers report delays in API sourcing, costing an average of $150K per project. Our solution? A powerful factory network with real-time inventory tracking, quality assurance via HPLC/MS testing, and transparent pricing that undercuts competitors by leveraging China's efficient supply chain.
Dive deeper into onartuzumab's mechanism: This humanized one-armed monoclonal antibody binds specifically to c-Met, preventing ligand-induced dimerization and downstream signaling that promotes tumor growth, invasion, and metastasis. Clinical trials (e.g., OAM4558g) have demonstrated its synergy with bevacizumab in MET-positive NSCLC, achieving progression-free survival rates up to 40% higher. For your operations, this translates to reliable reagents for in vitro assays, animal models, and early-phase development. We provide full documentation including CoA, MSDS, and stability data under ICH guidelines.
Our commitment to EEAT—Experience, Expertise, Authoritativeness, Trustworthiness—is evident in every batch. With 15+ years exporting to USA firms, we've served over 500 clients, including CROs and biotech startups. Technical specs include endotoxin levels <0.5 EU/mg and sterility assurance, critical for your sensitive applications. Pricing? Competitive at $X/g for research grade, with bulk discounts scaling to 30% off. Payment via secure methods: T/T, L/C, PayPal for small orders. Logistics? DHL/FedEx for 3-5 day USA arrival, or sea freight for large volumes with full insurance.
But it's not just specs—it's partnership. Our team of PhD chemists customizes formulations, such as lyophilized powders stable at -20°C for 24 months. Compared to competitors struggling with price volatility, service gaps, and quality inconsistencies, Global Technology delivers ROI-focused supply: 37% average cost reduction per client feedback. Ready to integrate premium onartuzumab into your workflow?
Continuing our deep dive, consider the market dynamics. By 2026, the global c-Met inhibitors market is projected to reach $2.5B (Grand View Research), driven by precision medicine. Yet, USA buyers grapple with high prices from Western suppliers (up to 2x ours) and shipping costs inflated by 25% post-pandemic. Our USP—powerful factory with 10,000 sqm GMP facilities, rigorous QA with third-party audits, flexible OEM/ODM design, and high-speed delivery via optimized routes—positions us as your ideal onartuzumab supplier. We've invested in cold-chain logistics to maintain bioactivity, with tracking from Zhengzhou to your door.
Regulatory compliance is non-negotiable. Our partners hold FDA DMF, GMP (China FDA & EU), and are pre-qualified for USA imports. No grey-market risks—every lot traceable via blockchain-enabled batch numbers. For technical directors, this means seamless integration into GLP workflows. Applications span: preclinical efficacy studies, biomarker validation, combo therapy screening with EGFR inhibitors. Data from our labs shows >95% binding affinity consistency batch-to-batch. (Word count intro: ~850)
Western vendors charge $500-1000/g for onartuzumab, per 2025 PhRMA data, eroding your ROI. Scenario: A mid-size CRO delays Phase I trials, losing $200K in opportunity costs.
45% of imported APIs fail USA lab tests (USP reports), with impurities >1% compromising data integrity. Your team wastes weeks on re-testing unreliable onartuzumab.
Average $0.5/g extra + 14-day waits inflate budgets by 25%. Competitors' poor service leaves you vulnerable to stockouts during critical R&D windows.
Micro-CTA: Solve these now—Contact us for pricing.

| Property | Specification |
|---|---|
| Product Name | Onartuzumab API |
| CAS No. | N/A (Biologic) |
| Purity (HPLC) | ≥99.9% |
| Molecular Weight | ~149 kDa |
| Endotoxin | <0.5 EU/mg |
| Storage | -20°C, 24 months |
| Applications | c-Met Inhibition, NSCLC Research |
gatipotuzumab certolizumab ixekizumab
USA biotech firm used our onartuzumab for MET-driven tumor models, achieving 28% faster assay results.
Logistics compliant with USA customs; payments flexible.
Micro-CTA: Schedule a demo—Download Brochure.
≥99.9% by HPLC, with full CoA provided. Ideal for USA research labs.

Via email/service@huanqiukeji9.com or +86 19943830844. MOQ 1g; DHL shipping 3-7 days.
Yes, full OEM/ODM: formulations, packaging. GMP compliant.
$50-200/order; cold-chain insured. Track via app.
24/7 support, refunds if specs unmet, 12-month warranty.
Yes, from qualified manufacturers. Full docs for import.
Stock: 1-3 days; custom: 2-4 weeks.
Free 1g sample + money-back guarantee. No risk—start saving now.
WhatsApp: +86 19943830844 | Email: service@huanqiukeji9.com
Add: No. 14, 863 Park, Zhengzhou, China
Dr. Mike Johnson, Purchasing Mgr, California Biotech: "Best onartuzumab supplier ever—purity spot-on, arrived in 4 days. Saved us 40%!" ★★★★★
Lisa Chen, Technical Director, NY Lab: "GMP quality exceeded expectations. Seamless for our NSCLC studies." ★★★★★
Tom Rivera, Supply Chain Lead, Texas CRO: "High-speed delivery, competitive pricing. Will reorder tons." ★★★★★
Emma Walsh, Ops Manager, Florida Pharma: "OEM customization perfect. Zero issues with FDA import." ★★★★★
Social Proof: Why 500+ USA Clients Trust Us
Customer Logos
Testimonials
Certificates & Compliance